Today is 2022-01-20

Cancelled by the investigator A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV
download

注册号:

Registration number:

ChiCTR2000030031 

最近更新日期:

Date of Last Refreshed on:

2020-03-16 

注册时间:

Date of Registration:

2020-02-21 

注册号状态:

预注册  

Registration Status:

Prospective registration  

注册题目:

研究者撤消 磷酸氯喹片联合标准疗法对比标准疗法治疗轻型/普通型2019冠状病毒肺炎(COVID-19)的随机、双盲、平行对照研究 

Public title:

Cancelled by the investigator A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

磷酸氯喹片联合标准疗法对比标准疗法治疗轻型/普通型2019冠状病毒肺炎(COVID-19)的随机、双盲、平行对照研究 

Scientific title:

A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)  

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

缪经纬 

研究负责人:

邓英 

Applicant:

Jingwei Miao 

Study leader:

Ying Deng 

申请注册联系人电话:

Applicant telephone:

+86 18998986610 

研究负责人电话:

Study leader's telephone:

+86 13500296796 

申请注册联系人传真 :

Applicant Fax:

+86 0763-3113605 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

qyrygcp@163.com 

研究负责人电子邮件:

Study leader's E-mail:

surewin001@126.com 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

广东省清远市清城区新城B24号区 

研究负责人通讯地址:

广东省清远市清城区曙光二路22号 

Applicant address:

B24 Area, Qingcheng District, Qingyuan, Guangdong, China 

Study leader's address:

22 Second Shuguang Road, Qingcheng District, Qingyuan, Guangdong, China 

申请注册联系人邮政编码:

Applicant postcode:

511518 

研究负责人邮政编码:

Study leader's postcode:

511518 

申请人所在单位:

广州医科大学附属第六医院(清远市人民医院) 

Applicant's institution:

The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital) 

是否获伦理委员会批准:

是 

Approved by ethic committee:

Yes 

伦理委员会批件文号:

Approved No. of ethic committee:

IRB-2020-002 

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

清远市人民医院医学伦理委员会 

Name of the ethic committee:

Institutional Review Board of Qingyuan People's Hospital 

伦理委员会批准日期:

Date of approved by ethic committee:

2020-02-19 

伦理委员会联系人:

邓源武 

Contact Name of the ethic committee:

Yuanwu Deng 

伦理委员会联系地址:

广东省清远市清城区新城B24号区 

Contact Address of the ethic committee:

B24 Area, Qingcheng District, Qingyuan, Guangdong, China 

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 0763-3113629 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

qyryllwyh@163.com 

研究实施负责(组长)单位:

广州医科大学附属第六医院(清远市人民医院) 

Primary sponsor:

The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital) 

研究实施负责(组长)单位地址:

广东省清远市清城区新城B24号区、曙光二路22号 

Primary sponsor's address:

B24 Area, Qingcheng District, Qingyuan, Guangdong, China 

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

清远

Country:

China

Province:

Guangdong

City:

Qingyuan

单位(医院):

广州医科大学附属第六医院(清远市人民医院)

具体地址:

广东省清远市清城区新城B24号区、曙光二路22号

Institution
hospital:

The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital)

Address:

B24 Area, Qingcheng District